Grey Matters Health Inc (PK)【AGNPF】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or...

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Grey Matters Improves Warrant Terms of Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or...

Grey Matters Announces Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

https://www.otcmarkets.com/stock/AGNPF/news/Grey-Matters-Health-Signs-LOI-with-Catalyst-MedTech-for-200-Brain-PET-Scans-for-Alzheimers-Clinical-Trial-at-2nd-NovaSca?e&id=3471387

👍️0

McMagyar 2月前

Don’t forget to cheat new Message board under GREY.
Looking forward to success here

👍️0

Renee 3月前

Algernon Health Inc changed to Grey Matters Health Inc and a one for 10 reverse split

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

👍️0

shell3 3月前

Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Health-Announces-Proposed-Name-Change-to-Grey-Matters-Health-Inc-and-a-101-Share-Consolidation?id=515986

👍️0

McMagyar 3月前

Chris way to keep the dream alive!!Let’s Roll!

👍️0

smoki 3月前

When’s the opening date 2035?

👍️ 1 😴 1

shell3 3月前

Here’s a Interview he did today or yesterday

👍️0

smoki 3月前

Hard to invest with this guy Chris after the last stock scenario he ran… ran away with my $$$$

👍️0

shell3 5月前

Outstanding: 47,332,431 for February 10, 2026

MONTHLY 5th PROGRESS REPORT

https://webfiles.thecse.com/1._Algernon_-_CSE_Form_7_-_January_2026.pdf?C78qpW.Nb_lK77bTuHEqzoHvZ2KjGI9Q

👍️0

shell3 6月前

Outstanding: 44,820,505

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_December_23_2025.pdf?fNc3eyIT0gmKMJ3niDEOjvyETrdzSVaG

👍️0

McMagyar 7月前

I give high praise to leadership and Chris Moreau!Instead of waiting for regulatory authorities to approve our Pharma for Stroke or other maladies..And long term.. there will most likely be a Cross Scripp of the Stroke Medicine for Neuronal Cell growth in dementia..so having the Clinics set up for early detection will appear to be a Master stroke of planning..The partnerships are excellent, well conceived and executed.Now if Chris can just avoid the expected patriarchal Canadian FU to the rest of the World by giving the Friends and Family Cheap Ass Discount of stock issuance we will all make a lot of money.. time will tell..Pressure will hard in that Canuck inner sanctum..We shall see if Moreau is a bird of a different feather.. I pray so

👍️0

shell3 8月前

Closing

Number of securities to be issued: 7,142,857 Units consisting of one Class A Common
Share and one-half Common Share purchase warrants.

Issued and outstandingsecurities following issuance: 41,398,976 Common Shares issued and outstanding and 1,718,334 Preferred Shares issued and outstanding.

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_November_6_2025.pdf?iOlkw6ceog7zbCXNPNSXRLYkFTVnpSev

👍️0

shell3 8月前

Algernon Health Announces Private Placement

https://webfiles.thecse.com/AGN_Health_Press_Release_-_Private_Placement.pdf?exJDT.59P4cu8ZjUQ9Bl4rTrSPiGqjWf

$0.07 $AGN
or
$0.050 United States Dollar $AGNPF

👍️0

shell3 8月前

Outstanding: 34,256,219 for November 5, 2025

Monthly 5th Report

https://webfiles.thecse.com/10._Algernon_-_CSE_Form_7_-_October_2025.pdf?wlc5NG8FNLEkAyPpA8SzVzbWVC3krFE9

👍️0

shell3 9月前

Name Change Coming

Algernon Pharmaceutical to Algernon Health Inc

Outstanding: 34,256,219 for October 7, 2025

Monthly 5th Report

https://webfiles.thecse.com/9._Algernon_-_CSE_Form_7_-_September_2025.pdf?MoUQcTJKHt61fZJ0AtntyNgGx6LnpdFm

👍️0

McMagyar 9月前

I've been lock out of my email for a couple of days.. super busy.. anyone repost the $4mill in non dilutive financing?

👍️0

shell3 10月前

Outstanding: 34,256,219 fr September 5th, 2025

Monthly 5th Report

https://webfiles.thecse.com/8._Algernon_-_CSE_Form_7_-_August_2025.pdf?LoWQ_Xtf4Hz7Cl4tuodpcIglupOUeV4K

👍️0

shell3 10月前

Algernon Pharmaceuticals Announces Name Change to Algernon Health

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Announces-Name-Change-to-Algernon-Health?id=491356

👍️0

shell3 11月前

Outstanding: 34,256,219 for August 7, 2025

Monthly 5th Report

https://webfiles.thecse.com/7._Algernon_-_CSE_Form_7_-_July_2025.pdf?ANM_dYUnzbisArZ68ElDBYR4crcSsmYK

👍️0

shell3 12月前

Outstanding: 34,256,219 for July 7, 2025

Monthly 5th Report

https://webfiles.thecse.com/6._Algernon_-_CSE_Form_7_-_June_2025.pdf?fxp.q7_rComPUPRC8molqRa.bjzefPim

👍️0

shell3 1年前

$0.044 United States Dollar $AGNPF

Changed from $0.07 CAD to $0.06 CAD per unit on the placement

👍️0

shell3 1年前

NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_June_30_2025.pdf?VacRdkjBC9wyjXF58YO2LvuUCTcSF0jJ

$0.075 $AGN or $0.055 $AGNPF

👍️0

McMagyar 1年前

Long termVery bullishInsider ownershipHome runs possible And all roads lead to better treatments for dementiaI would throw in some homeopathic Opportunities as well.. really make it a no brainer service

👍️0

McMagyar 1年前

Around 30,000,000 outHow much will a no brainer clinical sell for?How much income?I love itOne neuro group in every city

👍️0

shell3 1年前

Outstanding: 34,256,219 for June 10, 2025

Monthly 5th Report

https://webfiles.thecse.com/5._Algernon_-_CSE_Form_7_Monthly_Progress_Report_-_May_2025.pdf?dq.0S4or7PCmFbPRZOMr4cQr0q3znBY_

👍️0

shell3 1年前

MATERIAL CHANGE REPORT

The Acquisition cost some shares

5,000,000 Commons
5,000,000 Warrants @ $0.15 $AGN
which is $0.11 $AGNPF
450,000 Preferred (which convert to 10 Commons)
450,000 Preferred Warrants @ $1.50 $AGNPF

https://webfiles.thecse.com/AGN_-_material_change_report_-_NoBrainer_Acquisition_-_May_2025.pdf?TtUbNelliNHD6b47Dy5DEzEEQumgUbvI

👍️0

shell3 1年前

Issued and outstanding: 41,398,976 Shares issued and outstanding and 1,164,286 Preferred Shares to be issued upon shareholder
approval.

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_May_27_2025.pdf?7h0FADzO1U.f5j1GHZ1JtakX_vGULsLm

Here’s what came 1st to grow to 41.4M going to be Outstanding

https://webfiles.thecse.com/2._Algernon_CSE_Form_9_-_NoBrainer_Final.pdf?05nLb1ou6zdqlZ.W1bEwvqDMolSsF3r1

👍️0

shell3 1年前

Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-to-Acquire-NoBrainer-Imaging-Centers-Inc---Plans-to-Establish-Alzheimers-Diagnostic-and-Treatment-Medical-Clini?id=477047

👍 2

shell3 1年前

Outstanding: 28,756,219 for May 7, 2025

Monthly 5th Report

https://webfiles.thecse.com/4._Algernon_-_CSE_Form_7_-_April_2025.pdf?yK._riJP7jXr1l.nsO3MzXWng_vAgmHu

👍️0

shell3 1年前

Outstanding: 28,706,219 for April 3, 2025

Monthly 5th Report

https://webfiles.thecse.com/3._Algernon_-_CSE_Form_7_-_March_2025.pdf?omj5DHVectn4mLlb3ERYaKOOSpvdsjd0

1.4M shares added to Outstanding and looks like JFK Enterprises Ltd. bought in under James Kinley in March

👍️0

shell3 1年前

Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Receives-Notice-of-Allowance-from-European-Patent-Office-for-Repirinast-for-Kidney-Disease?id=472899

👍️0

shell3 1年前

Planned Regulation A Financing

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-NeuroScience-Engages-Netcapital-Securities-for-Planned-Regulation-A-Financing?id=469774

👍️0

shell3 1年前

Outstanding: 27,301,219 for March 5, 2025

Monthly 5th Report

https://webfiles.thecse.com/2._Algernon_-_CSE_Form_7_-_February_2025.pdf?1m_UXQap03YYSE8UYvl4CojNGCX9St22

👍️0

shell3 1年前

DMT Study Set To Explore Breakthrough Potential in Stroke Recovery

https://www.streetwisereports.com/article/2025/02/14/dmt-study-set-to-explore-breakthrough-potential-in-stroke-recovery.html?utm_source=AGN-CNX

👍️0

shell3 1年前

Outstanding: 27,301,219 for February 10, 2025

Monthly 5th Report

https://webfiles.thecse.com/Algernon_-_CSE_Form_7_-_January_2025.pdf?vminj6YZTkivyUTkEksmv48BrU2v6MZq

Note #13 is a good read

👍️0

tcm7 1年前

About Time for some Good news...

https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/213/algernon-neuroscience-appoints-validcare-as-cro-for-its

👍️0

shell3 1年前

Outstanding: 27,301,179 for January 6, 2025

Monthly 5th Report

https://webfiles.thecse.com/12._Algernon_-_CSE_Form_7_-_December_2024.pdf?9VwETA1schKXaKZEJfJQcpdOsqeBCd5Q

👍️0

shell3 1年前

Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Receives-Notice-of-Allowance-from-USPTO-For-Repirinast-in-Kidney-Disease-Patent?id=463673

👍 1

shell3 2年前

Outstanding: 27,301,179 for December 17, 2024

Monthly 5th Report

https://webfiles.thecse.com/11._Algernon_-_CSE_Form_7_-_November_2024.pdf?8zodTJV77.vDjjF3CmUvo1WJ4a9O5bpu

👍️0

shell3 2年前

Outstanding: 27,301,179 for November 6, 2024

Monthly 5th Report

https://webfiles.thecse.com/10._Algernon_-_CSE_Form_7_-_October_2024.pdf?dcBppEBh75EfB.9rOF7uL_qdPPt86f8S

400 Warrants issued in October @ $0.52 $AGN or $0.374 $AGNPF price (Market never went over $0.0688 $AGNPF the whole month of October and Buying Open Market would have been like 2,000 shares vs the same cost of 400 Warrants)

👍️0

shell3 2年前

NOTICE OF AMENDMENT OF WARRANT TERMS

They expire November 5th and change the date to expire May 5th 2025

But look how they left the price unchanged from to still $0.52 $AGN or $0.374 $AGNPF

Looks Bullish but I DON’T FEEL IT

https://webfiles.thecse.com/Final_Algernon_CSE-Form_13-Amendment-of_Warrant_Terms_-_Nov._2024.pdf?QLyYlN5KeNvboxvVrkU5kuy7e1jImpz4

👍️0

LuckyMarble 2年前

I have completely lost track of what might be next here with AGN. What are we waiting for? Is there anything going on at all? There is never any news, no video interviews, nothing to follow...what is potentially next???

👍️0

McMagyar 2年前

I still like management AND this stock..
I know.. oh well..
buy low!

👍️0

McMagyar 2年前

I am the worst stock picker ever..
Haha

👍️0

shell3 2年前

Outstanding: 27,300,779 for September 10, 2024

Monthly 5th Report

https://webfiles.thecse.com/8._Algernon_-_CSE_Form_7_-_August_2024.pdf?T0RnoT2MZl1XzWpHbNPjzdACkTKflj8P

👍️0

McMagyar 2年前

Actually one of few stocks I would own at this point… God help us all if the Marxists win .. they usually kill people before they take power..

👍️0

McMagyar 2年前

By all rights
The previous shareholders lost everything with failures..
You are buying a different proposition and insiders are invested..
It’s a better shot with DMT ..

I like it

Needed cash but if able will buy back in

👍️0

shell3 2年前

Offering is $0.0892 $AGNPF or $0.12 $AGN

Someone and Insiders Buying the Offering

But Insiders except Kinley has also sold most those others held on the last real run which does look bad and would expect them to also sell these bought when price is up - JMO

https://ceo.ca/agn

👍️0

McMagyar 2年前

My thinking is
Don’t sell

👍️0

shell3 2年前

CRY or LAUGH My Ass Off

To me it’s sad but someone is collecting shares for some reason - Volume just not there for selling for the same @ the Market Price

Algernon Pharmaceuticals Announces Increase to Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE)

https://webfiles.thecse.com/2024-08-13_Algernon_Pharmaceuticals_Announces_Increase_to_209.pdf?80FkHRyx35jcD3V97cSqfn8Fr.W2Qq5G

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Grey Matters Health Inc (PK) (AGNPF)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Grey Matters Health Inc (PK) (AGNPF) ニュース

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

Grey Matters Improves Warrant Terms of Private Placement

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Grey Matters Announces Private Placement

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

Form D/A - Notice of Exempt Offering of Securities: [Amend]

Form D - Notice of Exempt Offering of Securities

Algernon Closes Second Tranche of Private Placement Financing

AGNPF Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Grey Matters Health Inc (PK) (AGNPF)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Grey Matters Health Inc (PK) (AGNPF) ニュース

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

Grey Matters Improves Warrant Terms of Private Placement

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Grey Matters Announces Private Placement

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

Form D/A - Notice of Exempt Offering of Securities: [Amend]

Form D - Notice of Exempt Offering of Securities

Algernon Closes Second Tranche of Private Placement Financing

AGNPF Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する